Nirsevimab Administration and RSV Hospitalization in the 2024-2025 Season | Olfactory Dysfunction After SARS-CoV-2 Infection in the RECOVER Adult Cohort | FDA Conditionally Approves First Drug for Prevention and Treatment of New World Screwworm Infestations in Cattle September 30, 2025
Found under the ‘Resources’ tab of our website, the course was developed by Parasites Without Borders in conjunction with a team of fellows and medical educators at Columbia University Irving Medical Center and was revised by a panel of expert clinicians and researchers from all around the world.
Brand New Tropical Medicine Curriculum Unveiled Read More »
Clesrovimab for Prevention of RSV Disease in Healthy Infants | Mexico Boosts Controls on Cattle after New Screwworm Case Found Near U.S. Border in Nuevo Leon | More Measles Cases Now in 2025 Than Any Year Since It Was Declared Eliminated in 2000
September 25, 2025 Read More »
Tracking County-Level Measles Cases in the U.S. | Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza | Adverse Events Associated with COVID-19 Vaccination or Diagnosis among Pregnant and Non-pregnant Women in the United States, 2021-2022
September 18, 2025 Read More »
Risk Factors for Severe Outcomes of Respiratory Syncytial Virus Infection in Children: A Nationwide Cohort Study in Sweden | Spillover of SARS-CoV-2 to Domestic Dogs in COVID-19–Positive Households: A One Health Surveillance Study
September 13, 2025 Read More »
This popular podcast produced by MicrobeTV and featuring Dr. Daniel Griffin (MD, Ph.D. CTropMed CTH) and Dr. Sara Dong (Ph.D.), aims to be a trusted and accessible tool to help busy clinicians, researchers, students and citizen scientists keep up-to-date on the latest infectious disease literature.
Increasing Access for Infectious Disease Puscast Read More »
Risk of Myocarditis or Pericarditis With High-Dose vs Standard-Dose Influenza Vaccine A Prespecified Secondary Analysis of the Randomized DANFLU-2 Trial |
Three Pharmaceutical Companies Announce U.S. FDA Approval for Updated COVID. The U.S. FDA’s Center for Biologics Evaluation and Research has suspended the biologics license for Valneva Austria GmbH’s live – attenuated IXCHIQ vaccine.
Ivermectin to Control Malaria — A Cluster-Randomized Trial | Relative Effectiveness of High-dose versus Standard-dose Influenza Vaccine against Hospitalizations and Mortality According to Frailty Score: A Post-hoc Analysis of the DANFLU-1 Randomized Trial
Adjuvanted Recombinant Zoster Vaccine is Effective Against Herpes Zoster Ophthalmicus, and is Associated with Lower Risk of Acute Myocardial Infarction and Stroke in Adults Aged ≥50 Years |
A comprehensive educational resource on all aspects of parasitic diseases and their impact on humanity around the globe.
Help bring the latest medical and basic biological information pertaining to diseases caused by eukaryotic parasites to every practicing physician and medical student within the United States.
English 
Spanish